hepatitis B infection Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting hepatitis b infection clinical trials across 22 countries. Studies span Phase 1, Not Applicable, Phase 2. Top locations include Auckland, New Zealand, Baltimore, Maryland, United States, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


hepatitis B infection Trials at a Glance

7 actively recruiting trials for hepatitis b infection are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Phase 1 with 5 trials, with the heaviest enrollment activity in Auckland, Baltimore, and Barcelona. Lead sponsors running hepatitis b infection studies include Aligos Therapeutics, Ausper Biopharma Co., Ltd., and Bluejay Therapeutics, Inc.

Browse hepatitis b infection trials by phase

Treatments under study

About hepatitis B infection Clinical Trials

Looking for clinical trials for hepatitis B infection? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new hepatitis B infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about hepatitis B infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1

A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants

Chronic Hepatitis B Infection
Ausper Biopharma Co., Ltd.110 enrolled1 locationNCT07511218
Recruiting
Not Applicable

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test

hepatitis B infectionHIV-1-infectionSyphilis Infection+1 more
bioLytical Laboratories1,000 enrolled3 locationsNCT07563309
Recruiting
Phase 2

A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)

Chronic Hepatitis B Infection
Aligos Therapeutics200 enrolled58 locationsNCT06963710
Recruiting
Phase 1

Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function

Chronic Hepatitis B Infection
Aligos Therapeutics30 enrolled2 locationsNCT07342881
Recruiting
Phase 1

A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults

Chronic Hepatitis B Infection
Chimivac INC36 enrolled1 locationNCT07059403
Recruiting
Phase 1

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Cavrotolimod in Subjects with Chronic Hepatitis B Infection

Chronic Hepatitis B Infection
Bluejay Therapeutics, Inc40 enrolled6 locationsACTRN12624000808549
Recruiting
Phase 1

RO7191863 in patients with chronic hepatitis B

Chronic Hepatitis B Infection
F. Hoffmann-La Roche49 enrolled8 locationsACTRN12619000271101